S2199 S2200. * Speaker's diagnosis 78
|
|
|
- Christian Gregory
- 5 years ago
- Views:
Transcription
1 :30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma 5 Hemangiopericytoma 4 Glomangioma 1 Capillary endothelial hyperplasia 1 Meningoangiomatosis 1 Anaplastic astrocytoma 1 Glioma + hemangioma 1 Angiosarcoma 1 3 S2200 Meningioma 30 Papillary meningioma * 2 Astrocytoma 5 Pilocytic astrocytoma 3 Anaplastic astrocytoma 1 Tanycystic ependymoma 2 Pineocytoma 3 Pineoblastoma 3 Pineal parenchymal tumor 1 Pinealoma 1 Papillary tumor of the pineal region 2 Hemangioblastoma 1 Fibroblastoma 1 Inflammatory pseudotumor 1 1
2 Solitary fibrous tumor 1 Metastatic carcinoma 1 26 S2201 Chordoma 11 Meningioma 22 Chordoid meningioma * 8 Meningotheliomatous meningioma 1 Meningioma, myxoid variant 1 Angioblastic meningioma 2 Invasive meningioma 2 Hemangioendothelioma 18 Epithelioid hemangioendothelioma 14 Epithelioid hemangioma 1 Glomeruloid hemangioma 1 Glomus tumor 2 Myopericytoma 1 Perineuroma 1 Giant cell tumor 1 Myxoma 1 Myxofibrosarcoma 5 low-grade 1 Mucoepidermoid carcinoma 2 Malignant peripheral nerve sheath tumor 1 Rhabdomyosarcoma 1 Angiosarcoma 1 9 S2202 Undifferentiated carcinoma*/ anaplastic carcinoma 47 exhibiting extreme pleomorphism with giant cells 1 Pleomorphic carcinoma 4 Acinic cell carcinoma 1 Malignant lymphoma 14 DLBCL 3 Anaplastic large cell lymphoma 7 Intravascular lymphomatosis 1 2
3 Anaplastic carcinoma + anaplastic large cell lymphoma 1 Malignant melanoma 4 Malignant rhabdoid tumor 1 Anaplastic tumor 1 Histiocytic sarcoma 1 Giant cell tumor 1 3 S2203 Papillary fibroelastoma * 53 Myxoma 2 Elastofibroma 1 Intimal tumor 1 Mesothelioma 1 Carcinoid tumor 1 19 S2204 Malignant lymphoma 53 Hodgkin lymphoma 25 + pseudocarcinomatous lesion 1 MALT / BALT / Marginal zone B-cell lymphoma 18 + adenocarcinoma 1 + deposition of immunoglobulin-derived substance 1 Hodgkin lymphoma and MALT lymphoma * 3 Lymphomatoid granulomatosis 2 Inflammatory pseudotumor 7 IgG4-related 2 Inflammatory myofibroblastic tumor / myofibroblastic tumor 6 Angioimmunoproliferative lesion 1 Lymphoproliferative lesion + adenoma 1 Pulmonary blastoma 1 Sclerosing hemangioma 1 Acinar adenocarcinoma + TALP 1 Lymphoepithelioma-like carcinoma 2 3 3
4 S2205 Adenoid cystic carcinoma * 72 + Collagenous spherulosis 1 Invasive cribriform carcinoma 1 Myoepithelial carcinoma 1 Ductal adenoma 1 Collagenous spherulosis 1 2 S2206 Granular cell tumor * 31 Apocrine carcinoma 9 Medullary carcinoma 4 Atypical medullary carcinoma 1 Oncocytic carcinoma 1 Invasive ductal carcinoma with endocrine features 1 Lipid-rich carcinoma 1 Inflammatory pseudotumor 1 Fibrous disease 1 Granulomatous inflammation 1 28 S2207 Adenocarcinoma 56 Poorly differentiated adenocarcinoma 10 Poorly differentiated adenocarcinoma with lymphoid stroma 14 Lymphoepithelioma-like (adeno)carcinoma 13 EBV-related adenocarcinoma 5 Lymphoepithelioma-like carcinoma with squamous differentiation 4 Medullary carcinoma 5 EBV-related 2 Adenoacanthoma 1 Hepatoid adenocarcinoma 1 Adenocarcinoma (NOS) 3 Adenosquamous carcinoma 5 with lymphoid stroma 1 Mucoepidermoid carcinoma 4 Endocrine carcinoma 1 4
5 Adenocarcinoma + adenosquamous carcinoma 5 Lymphoepithelioma-like carcinoma + adenosquamous carcinoma * 2 Composite carcinoma, adenocarcinoma + adenosquamous carcinoma 1 Poorly differentiated adenocarcinoma with lymphoid stroma + adenosquamous carcinoma with mucoepidermoid morphology 1 Medullary carcinoma + adenosquamous carcinoma 1 Adenocarcinoma + mucoepidermoid carcinoma 2 Adenocarcinoma + neuroendocrine carcinoma 1 EBV-associated adenoma 2 2 S2208 Endometriosis * 75 with focal mucosal pseudodecidual change 1 Lymphangioma 1 2 S2209 Hepatocellular carcinoma, sarcomatoid 4 Cholangiocellular carcinoma 4 sarcomatoid 3 Bile duct cystadenocarcinoma 1 Adenosarcoma 1 Carcinosarcoma * 40 heterologous 1 mixed HCC and CCC, osteosarcoma and chondrosarcoma 1 + Biliary cystadenoma 1 Nonhepatocytic malignant mixed tumor 3 Malignant mixed hepatic tumor 1 Hepatoblastoma 10 mixed epithelial and mesenchymal 2 mixed epithelial and mesenchymal, with teratoid features 2 Embryonal sarcoma 5 Hamartomatous mixed tumor 1 Hamartoma 2 Mesenchymal 1 Immature teratoma 1 5 5
6 S2210 Juxtaglomerular cell tumor * 41 renin-producing renal cell tumor 1 Pheochromocytoma 5 Paraganglioma 2 Angiomyolipoma 3 Glomus tumor 1 Epithelioid hemangioma 1 Hemangiopericytoma 2 Hemangioendothelioma 1 Renal cell carcinoma 2 Bellini duct carcinoma 1 19 S2211 Oncocytoma * 41 Tubulocystic oncocytoma 1 Oncocytic cystic adenoma 1 + Cavernous hemangioma 1 Oncocytosis (oncocytomatosis) 1 Angiomyolioma, oncocytoma-like 1 Renal cell carcinoma 26 Granular cell carcinoma 6 Oncocyic carcinoma 2 Papillary renal cell carcinoma 2 Clear cell carcinoma 1 Oxyphilic carcinoma + malakoplakia 1 Bellini duct carcinoma / Collecting duct carcinoma 4 5 S2212 Mucinous tubular and spindle cell carcinoma * 51 Renal cell carcinoma (NOS) 10 unclassified 3 undifferentiated type 1 G3 1 Spindle cell / sarcomatoid carcinoma 5 Renal medullary carcinoma 3 6
7 Clear cell carcinoma 3 with tubular differentiation 1 granular cell subtype 1 Bellini duct carcinoma / collecting duct carcinoma 2 Mixed epithelial and stromal tumor 1 3 S2213 Adenocarcinoma (NOS) 12 Mucinous adenocarcinoma 45 Villoglandular (papillary) adenocarcinoma * 35 papillary type 1 endocervical type 2 gastric type 1 G-CSF producing? 1 Endometrioid adenocarcinoma 11 villoglandular variant 1 Papillary adenocarcinoma 4 Villous adenocarcinoma 1 Villonodular adenocarcinoma 1 endocervical type 2 Villonodular adenoma 1 3 S2214 Placental site trophoblastic tumor (PSTT) * 46 Epithelioid trophoblastic tumor 5 Endometrial stromal sarcoma 5 undifferentiated 1 Leiomyosarcoma 3 epithelioid 1 Perivascular epithelioid cell tumor (PEComa) 2 Choriocarcinoma 8 Clear cell carcinoma 1 Undifferentiated carcinoma 1 Carcinosarcoma 1 6 7
8 S2215 Fibrous pseudotumor * 24 Fibromatous periorchitis 9 IgG4-related? 1 Chronic proliferative periorchitis 3 Calcifying fibrous tumor 7 Inflammatory pseudotumor / Proliferative funiculitis 10 Inflammatory myofibroblastic tumor / plasma cell granuloma 12 Hypocellular inflammatory myofibroblastic tumor 1 IgG4-related 3 IgG4-related sclerosing disease/fibrosis 6 Solitary fibrous tumor 6 Fibroma 3 Burned-out testicular tumor 2 Mesothelioma 2 Desmoid 1 Inflammatory fibrous tumor 1 Chronic sclerosing inflammation 1 Fibrous overgrowth 1 2 S2216 Choriocarcinoma 2 Dysgerminoma 4 with syncytiotrophoblastic giant cells 3 Mixed germ cell tumor 52 Dysgerminoma + Choriocarcinoma 17 Dysgerminoma + Choriocarcinoma + Yolk sac tumor 7 Dysgerminoma + Choriocarcinoma + Embryonal carcinoma 4 Dysgerminoma + Choriocarcinoma + Carcinoid 2 Dysgerminoma + Choriocarcinoma + Teratoma 1 Dysgerminoma + Embryonal carcinoma 1 Choriocarcinoma + Yolk sac tumor 1 Gonadoblastoma 2 Gonadoblastoma + germ cell tumor 7 Mixed germ cell tumor with gonadoblastoma * 1 + Choriocarcinoma 1 + Dysgerminoma + Choriocarcinoma 4 8
9 + Dysgerminoma + Choriocarcinoma + Yolk sac tumor 1 Mixed germ cell-sex cord-stromal tumor 2 Mixed germ cell-sex cord-stromal tumor + germ cell tumor 5 + Choriocarcinoma 1 + Dysgerminoma + Choriocarcinoma 4 Cystadenocarcinoma 1 Endometrioid carcinoma with choriocarcinoma differentiation 1 3 S2217 : Osteosarcoma 34 Osteosarcoma in fibrous dysplasia 6 Low-grade central osteosarcoma 3 Osteosarcoma, well differentiated 2 Osteosarcoma, fibroblastic 2 Parosteal osteosarcoma 1 Malignant fibrous histiocytoma 14 Malignant fibrous histiocytoma in fibrous dysplasia 1 Fibrosarcoma 2 Dedifferentiated liposarcoma 1 Sarcoma in fibrous dysplasia 2 Fibrous dysplasia with malignant transformation * 5 Fibrous dysplasia 10 + Fibrous histiocytoma 1 Osteofibrous dysplasia 1 Aneurysmal bone cyst 1 Simple bone cyst 1 Fibrous histiocytoma 1 6 S2218 Malignant lymphoma 67 Hodgkin lymphoma 42 Anaplastic large cell lymphoma 6 Peripheral T-cell lymphoma 6 NOS * 2 DLBCL 3 Age-related EBV associated B-cell lymphoproliferative disorder 2 9
10 Non-Hodgkin lymphoma 1 Dendritic cell sarcoma 1 Langerhans cell sarcoma 1 Histiocytic sarcoma 1 Malignant fibrous histiocytoma 1 Metastatic carcinoma 1 Langerhans cell histiocytosis 2 4 S2219 MPNST / malignant schwannoma 18 Liposarcoma 10 Myxoid liposarcoma 3 Dedifferentiated liposarcoma 2 Low grade fibromyxoid sarcoma 4 Myxofibrosarcoma 3 Low grade myofibroblastic sarcoma 1 Angiomyxoid tumor, malignant 1 Sarcoma 1 Myxoid dermatofibrosarcoma protuberans * 2 Solitary fibrous tumor 4 myxoid type 1 Cellular angiofibroma 5 Neurofibroma 9 Diffuse neurofibroma 1 Schwannoma/neurilemmoma 4 Cellular schwannoma 1 Perineurioma 1 Angiomatosis of peripheral nerve 1 Angioblastoma 1 Angiomyofibroblastoma 2 Angiofibroma 1 Angiomyofibroma 1 Angiomyxofibroma 1 Angiomatous fibroma 1 Spindle cell tumor, NOS
11 S2220 Myofibroma / Infantile myofibromatosis 20 Fibromatosis 10 Infantile fibromatosis 7 Inclusion body fibromatosis 1 Fibrous hamartoma of infancy 2 Infantile myofibroblastoma 1 Dermatofibroma 3 Fibrous histiocytoma 2 Leiomyoma 2 Rhabdomyoma 2 Fetal rhabdomyoma 1 Fibroma 1 Neurofibroma 2 Schwannoma 5 Cellular schwannoma 2 Perineurioma 2 Hybrid schwannoma/perineurioma * 1 Hybrid peripheral nerve sheath tumor (schwannoma-neurofibroma-perineurioma) 1 Atypical fibroxanthoma 1 Fibrosarcoma 8 Infantile / Juvenile 7 Dermatofibrosarcoma protuberans 5 Infantile myofibrosarcoma 1 Low grade fibromyxoid sarcoma 1 Low grade myofibroblastic sarcoma 1 Spindle cell rhabdomyosarcoma 1 Mucinous tubular and spindle cell carcinoma
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
E-Path A.I. Engine Knowledge Base Enhancements Version 1.0.0.29 April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions 1.0.0.28 through 1.0.0.29 are as follows: 1. Addition/modification
S2326. Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1
S2325 Encephalitis 21 Encephalitis 4 Cerebritis 1 Meningoencephalitis 4 Acute disseminated encephalomyelitis 2 Acute encephalitis(virus) 1 Herpes simplex encephalitis* 2 Encephalitis, viral infection?
Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology
Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance
* Speaker's diagnosis
* Speaker's diagnosis Creutzfeldt-Jacob disease(cjd) 5 Prion disease( Creutzfeldt-Jakob disease ) 3 Extrapontine myelinolytis 5 Subacute sclerosing panencephalitis (SSPE) 5 Central pontine myelinolysis
Index. J Juvenile hyaline fibromatosis, 27 Juvenile xanthogranuloma, 57 Juxta-articular myxoma, 152
A Adenomatoid tumor, 76, 77 Adipose tissue tumors benign tumors angiolipoma, 6 chondroid lipoma, 9 fibrolipoma, 5 hibernoma, 8 lipoblastoma, 9 lipoma (see Lipoma) myelolipoma, 6 pleomorphic lipoma, 8 spindle
ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
16 Nuchal Fibroma and Gardner
C O N T E N T S Dedication v Preface vii Acknowledgments ix SECTION 1 Fibrohistiocytic Tumors 1 1 Classification of Fibrohistiocytic Tumors 3 2 Dermatofibroma 5 3 Juvenile Xanthogranuloma 33 4 5 6 Solitary
INDEX. in this web service Cambridge University Press
actin 14 adamantinoma 202, 290 292, 297 adenocarcinoma 136 adipocytes in hibernoma 149, 150 in lipoblastoma 148 in lipoma 141, 142, 145 in liposarcoma 152 in myelolipoma 151 adrenal gland tumors see myelolipoma
Surveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2018 Participant Summary 2018 College of American Pathologists. The College does not permit
Diagnostic Approach to Soft Tissue Tumors
SECTION 2 Diagnostic Approach to Soft Tissue Tumors Overview Biopsy and Resection of Soft Tissue Tumors 20 Clinical Approach Age- and Location-Based Approach to Diagnosis 24 Histologic Approach Pattern-Based
Appendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
Grading of Bone Tumors
Grading of Bone Tumors Joon Hyuk Choi, M.D. Department of Pathology College of Medicine, Yeungnam University Introduction to grading system of bone tumor used at Mayo Clinic WHO Histologic Classification
Methoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases
Adrenal cortical carcinoma Inhibin Synap Melan-A Calretinin Vimentin Chromogr CK7 CK20 Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017)
APPENDIX I. SEER Search criteria and exclusion criteria. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version 8.3.4 (downloaded 3/23/2017) SEER*Stat Database:
Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon
Introduction to Musculoskeletal Tumors James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon www.tumorsurgery.org Definitions Primary Bone / Soft tissue tumors Mesenchymally derived tumors (Mesodermal)
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Dermatitis Psoriasis Lichen Simplex Chronicus Foreign Body
S Y M P O S I U M P R O G R A M
Dear colleagues, dear friends We would like to cordially welcome you to the 10 th International Arkadi M. Rywlin International Pathology Slide Seminar in Anatomic Pathology to be held in Split, Croatia.
Supplementary Information
Rise in Glioblastoma Multiforme incidence in England 1995 2015 suggests an adverse environmental or lifestyle factor Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O Carroll Supplementary
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid. So-called multicystic benign mesothelioma. A, Gross appearance. So-called multicystic benign mesothelioma.
incidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour
Case E1 Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour Tumour 1 Upper pole tumour 28mm macro diameter Circumscribed Friable cut surface Tumour 2 Middle pole Part solid
Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
SURVEYS 2013 INDEX CASE SUMMARY REPORT. Performance Improvement Program in Surgical Pathology AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
INDEX Performance Improvement Program in Surgical Pathology SURVEYS 2013 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 1989-2013 CASE SUMMARY REPORT 2013 College of American Pathologists. The College does
Differential Diagnosis of Oral Masses. Palatal Lesions
Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides Effective January 1, 2015 California Tumor Tissue Registry 11021 Campus Street, Ah335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides Effective July 19, 2018 California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
ANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
BSG/TSL GI workshops EQA011 preliminary response analysis
BSG/TSL GI workshops 06 EQA0 preliminary response analysis GI Neoplasia case Female 68 years Oesophagus Tumour TN0 pre-op staging : No chemotherapy Adenoid cystic carcinoma (pt) Adenocarcinoma (ptb, ptbn)
Rare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
Anatomic Pathology Study Sets Glass Slides
Anatomic Pathology Study Sets Glass Slides California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, Ca 92350 (909) 558-4788; Fax (909) 558-0188 E-Mail: cttr@llu.edu Web Site: www.cttr.org
Index* Biphasic carcinoma, 267 Black thyroid, 104 BRAF genes, 37 BRAF mutations, in papillary carcinoma, 371
Index* A ADASP (Association of Directors of Anatomic and Surgical Pathology) reporting protocol, 468 Adenochondroma, 78 Adenoid cystic carcinoma, 320 Adenoid cystic variant of papillary carcinoma, 431
Chapter 4. Histological groups
Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based
第 121 回中国四国スライドカンファレンス投票結果
第 121 回中国四国スライドカンファレンス投票結果 S2633 肝腫瘤 Angiosarcoma 4 Hemangioendothelioma 9 Epithelioid 7 Atypical 1 Sclerosed hemangioma 11 Ancient hemangioma 1 Angiomyxoma 7 Aggressive angiomyxoma 4 Embryonal sarcoma
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,
PIP-D SURVEYS Performance Improvement Program in Surgical Pathology AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
PIP-D Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 2012 PIP/PIPW-D PARTICIPANT SUMMARY Program Update This report summarizes the diagnostic
Normal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
SURVEYS 2016 INDEX. Performance Improvement Program in Surgical Pathology CASE SUMMARY REPORT AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS
INDEX Performance Improvement Program in Surgical Pathology SURVEYS 2016 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS 1989-2016 CASE SUMMARY REPORT 2016 College of American Pathologists. The College does
BSG/TSL GI workshops EQA011 final response analysis with diagnoses
BSG/TSL GI workshops 2016 EQA011 final response analysis with diagnoses GI Neoplasia case 1 Female 68 years Oesophagus Tumour T2N0 pre-op staging : No chemotherapy Adenoid cystic carcinoma (pt1) 4 Adenocarcinoma
Minimally invasive adenocarcinoma. 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS)
Minimally invasive adenocarcinoma 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS) 2b lepidic acinar 2c papillary micropapillary solid 2d cribriform
ATLAS OF ATLAS OF. Leslie G. Dodd Marilyn M. Bui. with histologic, cytologic, and radiologic correlations. Leslie G. Dodd, MD Marilyn M.
with histologic, cytologic, and radiologic correlations Leslie G. Dodd, MD Marilyn M. Bui, MD, PhD This is an abundantly illustrated resource for diagnosis of bone and soft tissue lesions a particular
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY JULY, 2003 The following is a conceptual curriculum and set of guidelines for Pathology Residents on the Breast
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
Patients Treated with Leksell Gamma Knife
Patients Treated with Leksell Gamma Knife 1968-2016 TREATMENTS REPORTED 2016 BY REGION AND INDICATION INDICATION Asia excl. Europe Latin Middle East & Africa North Grand Total Benign Tumors 12283 9778
Tinh hoàn
Tinh hoàn Tinh hoàn Tinh hoàn Tiền liệt tuyến Tiền liệt tuyến Mào tinh hoàn Mào tinh hoàn Túi tinh Túi tinh Túi tinh Túi tinh So-called cystadenoma of seminal vesicle. Gross appearance of granulomatous
The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository
The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository Tumours diagnosed between 2006 and 2008 West Midlands Cancer Intelligence Unit Completeness of cancer data 2008 Soft
Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner
Review of the AP Part II Practical Examination Dr David Clift Co Chief Examiner General Remarks The part II practical examination involved 15 cases which were presented with sufficient clinical data to
Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
INDEX. in this web service Cambridge University Press
abscess. See also subareolar abscess acute mastitis, 44 lactational/puerperal mastitis, 55 mammary tuberculosis, 42 tuberculous, 43 adeno gastric, 198, 200 invasive, 157 lung, 197, 200 prostatic, 199 200
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms
Human Pathology (2008) 39, 1519 1526 www.elsevier.com/locate/humpath Original contribution GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms William
3/27/2017. Disclosure of Relevant Financial Relationships
Ophthalmic Pathology Evening Specialty Conference USCAP 2017 5 th March, 2017 Mukul K. Divatia, MD Assistant Professor Department of Pathology & Genomic Medicine Weill Cornell Medical College Houston Methodist
Protocol for the Examination of Lymphadenectomy Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis
Protocol for the Examination of Specimens From Patients With Malignant Germ Cell and Sex Cord-Stromal Tumors of the Testis Version: Testis 4.0.1.1 Protocol Posting Date: February 2019 Accreditation Requirements
Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist
Spindle Cell Lesions Of The Breast Emad Rakha Professor of Breast Pathology and Consultant Pathologist * SCLs comprise a wide spectrum of diseases, ranging from reactive processes to aggressive malignant
日本病理学会中国四国支部学術集会 ( 第 107 回スライドカンファレンス ) 診断投票結果平成 24 年 2 月 18 日 徳島大学医学部基礎第二講義室
日本病理学会中国四国支部学術集会 ( 第 107 回スライドカンファレンス ) 診断投票結果平成 24 年 2 月 18 日 徳島大学医学部基礎第二講義室 *:Speaker's diagnosis S2376 脳生検の一例 Demyelinating pseudotumor 5 * Demyelinating lesion 3 Demyelinating disease 1 Multiple sclerosis
Case year female. Routine Pap smear
Case 1 57 year female Routine Pap smear Diagnosis? 1. Atypical glandular cells of unknown significance (AGUS) 2. Endocervical AIS 3. Endocervical adenocarcinoma 4. Endometrial adenocarcinoma 5. Adenocarcinoma
Acknowledgments Contributors
Contents Preface Acknowledgments Contributors vii ix xix CHAPTER 1 Normal Cell Ultrastructure and Function 1 Cytoplasmic Organelles 1 Cytoskeleton (Cytoplasmic Matrix Structures) 4 Cytoplasmic Inclusions
PIP-A. Performance Improvement Program in Surgical Pathology SURVEYS 2011 & ANATOMIC PATHOLOGY EDUCATION PROGRAMS
PIP-A Performance Improvement Program in Surgical Pathology SURVEYS 2011 & ANATOMIC PATHOLOGY EDUCATION PROGRAMS 2011 PIP-A PARTICIPANT SUMMARY Program Update This report summarizes the diagnostic responses
Lung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
Classification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.
Non-epithelial tumours and nonepithelial tumour-like lesions of the bladder Dr Jonathan H Shanks The Christie NHS Foundation Trust, Manchester, UK Classification (1) Myofibroblastic proliferations and
5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani
5/10 Pathology Soft tissue tumors Mohammed Alorjani Farah Bhani Slides are included in this sheet. Objectives: Soft tissue tumors 1. Describe soft tissue tumors. 2. Understand the classification of soft
Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie
Molecular pathology in soft tissue tumors Sylvia Höller Pathologie When do we perform molecular testing? Morphology and IHC are not clearly fitting with an entity some translocations are entity specific
Atlas of Eyelid and Conjunctival Tumors
Atlas of Eyelid and Conjunctival Tumors Jerry A. Shields, M.D. Director, Ocular Oncology Service Wills Eye Hospital Professor of Ophthalmology Thomas Jefferson University Philadelphia, Pennsylvania Carol
Surveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2017 Participant Summary 2017 College of American Pathologists. The College does not permit
SUPPLEMENTARY INFORMATION
Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent
EQA 013 for the Nov 2017 workshops. Final analysis of responses received with Diagnoses
EQA 013 for the Nov 2017 workshops Final analysis of responses received with Diagnoses Case 1 Non-ulcerated solitary circumscribed scalp nodule, Male 44 yrs. Basal cell carcinoma 8 Trichoepithelioma 1
2003 PIP-A A Cases. Paul K. Shitabata, M.D. APMG May 21, 2003
2003 PIP-A A Cases Paul K. Shitabata, M.D. APMG May 21, 2003 Case 1 47F pelvic mass involving the right fallopian tube 5.5 cm intraluminal mass Fallopian Tube Adenocarcinoma Risk factors Breast, endometrial,
Tumors of the Fetus and Infant
Tumors of the Fetus and Infant Hart Isaacs, Jr Tumors of the Fetus and Infant An Atlas Second Edition Hart Isaacs, Jr Department of Pathology Rady Childrens Hospital San Diego University of California
Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
FINALIZED SEER SINQ S NOVEMBER 2011
: 20110133 Multiple primaries/heme & Lymphoid Neoplasms: A patient was diagnosed 7/31/08 with DLBCL (9680/3) (biopsy left supraclav. node), stage IIIB. Treated with chemo. 10/14/10 biopsy right supraclav.
Newer soft tissue entities
Newer soft tissue entities Examples among fibroblastic tumors Turku, May 6, 2010 Markku Miettinen, M.D. AFIP, Washington, DC Fibroblastic neoplasms Solitary fibrous tumor /Hemangiopericytoma Low-grade
Diagnostic Cytology of Cancer Cases
Diagnostic Cytology of Cancer Cases Somporn Techangamsuwan Companion Animal Cancer Research Unit (CAC-RU) Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University 1 Tumor or Non-tumor
Abid Irshad, MD Director Breast Imaging. Medical University of South Carolina Charleston
Abid Irshad, MD Director Breast Imaging Medical University of South Carolina Charleston Cases Financial disclosure: I or my family have no financial interest related to the material discussed in this presentation
ANATOMICAL PATHOLOGY STUDY SETS DIGITAL
ANATOMICAL PATHOLOGY STUDY SETS DIGITAL California Tumor Tissue Registry 11021 Campus Street, AH335, Loma Linda, CA 92350 (909) 558-4788; FAX (909) 558-0188 E-mail: cttr@llu.edu Website: www.cttr.org *
Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults
Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency
Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences
Gen Thorac Cardiovasc Surg (2013) 61:435 447 DOI 10.1007/s11748-013-0214-8 CURRENT TOPICS REVIEW ARTICLE Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences Jun
Performance Improvement Program in Surgical Pathology
PIP-D Performance Improvement Program in Surgical Pathology PARTICIPANT SUMMARY 2008 College of American Pathologists. The College does not permit reproduction of any substantial portion of the material
Educational Cases EQA November T.J. Palmer Raigmore Hospital Inverness
Educational Cases EQA November 2013 T.J. Palmer Raigmore Hospital Inverness Case 2 Clinical Details Dob 11 February 1951 PMH: 1964 Extraction of 45 aet 13 yr 1966 Cyst between 44 and 46 enucleated 1973
List of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
EQA014 for the May 2018 Workshops. Final analysis of responses received with diagnoses
EQA014 for the May 2018 Workshops Final analysis of responses received with diagnoses CASE 1: 36 yrs. F. Maxilla lesion. Odontogenic fibroma 1 Angiofibroma 1 Odontogenic myxoma 1 Arteriovenous malformation
Notice of Faculty Disclosure
Mesenchymal Tumors of the Vulva: Old, New, Something(s) Different Napa Valley Conference Pathology Education Partners Inc May 15, 2018 Teri A. Longacre, M.D. longacre@stanford.edu Stanford University,
CODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
Pathology of Mediastinal Tumors
SAMO Meeting Lucerne 2009 Pathology of Mediastinal Tumors Alex Soltermann Most common lesions (adults) Clinical presentation 50% of the patients are asymptomatic, lesion discovered incidentally Symptoms
CANCER REGISTRY 2002
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
2010 Update. NAACCR Webinar Series 1 4/1/2010. Agenda. Access to 2010 Information. CSv2. Collecting Cancer Data: Soft Tissue Sarcoma
NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Soft Tissue Sarcoma, Neuroendocrine Tumors (NET) and Gastrointestinal Stromal Tumors (GIST) Agenda Updates Soft Tissue Sarcoma Overview CSv2 MP/H
Surveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-A 2018 Participant Summary 2018 College of American Pathologists. The College does not permit
Appendix A Morphology of Neoplasms
Appendix A Morphology of Neoplasms The World Health Organization has published an adaptation of the International Classification of Diseases for Oncology (ICD-O). It contains a coded nomenclature for the
Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology
Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology Tumors of skeletal muscle: Rhabdomyomas and rhabdomyosarcomas Embryonal muscle 2 3 4 5 6 7 8 Rhabdomyoma Benign
Neoplasms of the Heart, Pericardium, and Great Vessels Histopathology Reporting Guide
Neoplasms of the Heart, Pericardium, and Great Vessels Histopathology Reporting Guide Family/Last name Gender Male Female Given name(s) Date of birth DD MM YYYY Patient identifiers Date of request Accession/Laboratory
Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse. March, 2000
Spontaneous Neoplastic Lesions in the Crl:CD-1 (ICR)BR Mouse March, 2000 Information Prepared by Mary L. A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES RIVER LABORATORIES TABLE OF CONTENTS
2% of all malignancies Male predominance Patients usually more than 60 years old
Benign Bladder Tumors Transitional Cell Papilloma 2-3% Inverted Papilloma Rare Malignant Transitional (Urothelial) Carcinoma 90% Carcinoma In-Situ (By Itself) 5-10% Squamous Cell Carcinoma 3-7% Adenocarcinoma
Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust
Dr Sanjiv Manek Oxford Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust Ovarian Endometrial Vulvo-vaginal Cervical Illustration-Cellular Pathology. Oxford
Diagnostically Challenging Cases in Gynecologic Pathology
Diagnostically Challenging Cases in Gynecologic Pathology Eric C. Huang, M.D., Ph.D. Department of Pathology and Laboratory Medicine University of California, Davis Medical Center Case 1 Presentation 38